ABSTRACT Four cattle parasiticides of the avermectin/milbemycin class were examined for lethal and sublethal effects on the zoophilic, African malaria vector Anopheles arabiensis. Ivermectin, moxidectin, doramectin, and eprinomectin were mixed with bovine blood and provided to laboratoryreared An. arabiensis in a membrane feeder. Ivermectin and eprinomectin were lethal to An. arabiensis at low concentrations (LC 50 s of 7.9 ppb and 8.5 ppb, respectively). While the lethality of doramectin (LC 50 of 23.9 ppb), was less than that of ivermectin and eprinomectin, it markedly reduced egg development. The concentration of moxidectin required to reduce survivorship and egg production in An. arabiensis was Ͼ100 fold greater than for ivermectin or eprinomectin. Moxidectin was weak in its actions against An. arabiensis relative to the other three chemicals. These results suggest that cattle treated with ivermectin or eprinomectin in the prescribed range of low dosages as parasiticides have blood toxic to zoophilic malaria vectors. Regionally coordinated, seasonal treatment of cattle could suppress An. arabiensis populations, thereby reducing malaria transmission. Doramectin (although less toxic) would have population level effects on egg production if used in this manner.
Avermectins are glutamate-gated chloride channel activators that cause reduced motor activity and paralysis in both insects and nematodes (Martin et al. 2002) . In cattle, the species spectrum of ivermectin activity ranges from parasitic nematodes, mites, ticks, lice, and ßy larvae (Benz et al. 1989 ) to certain species of mosquito (Iakubovich et al. 1989 , Tesh and Guzman 1990 , Bockarie et al. 1999 , Foley et al. 2000 , Fritz et al. 2009 , Chaccour et al. 2010 . Ivermectin is a member of the avermectin class, capable of reducing both endoand ectoparasite burden in livestock. Circulating ivermectin in the blood of treated hosts reduces survivorship of the mosquitoes that fed on them in both laboratory and controlled Þeld settings (Bockarie et al. 1999 , Fritz et al. 2009 , Chaccour et al. 2010 . For example, treatment of cattle at 600 g/kg active ingredient (AI) yielded sufÞciently high ivermectin blood plasma titers to produce Ͼ90% mortality in the Anopheles mosquitoes feeding upon them within 2 wk posttreatment (Fritz et al. 2009 ).
The most widespread vector control methods currently in use are insecticide-treated bed nets and indoor residual spraying, both of which reduce mosquito survivorship and successful human blood meal acquisition (Molineaux and Gramiccia 1980 , Killeen and Smith 2007 ). These control measures are less effective at reducing blood meal acquisition (Killeen and Smith 2007) , and vector abundance (Bayoh et al. 2010 ) for zoophilic vectors like An. arabiensis, compared with anthropophilic vectors like An. gambiae. In some cases, cattle serve as adequate hosts when humans are unavailable (Lefevre et al. 2009 ), allowing vector populations to persist. In malaria endemic areas, timed mass treatments of livestock with ivermectin could reduce zoophilic vector populations at the onset of the rainy season, precluding epidemics (Foley et al. 2000 , Fritz et al. 2009 ). In addition, beneÞts for cattle shareholders would extend beyond malaria control, by reducing parasite burden of the cattle (Ciordia et al. 1984 , Roncalli and Benitez Usher 1988 , Dimander et al. 2003 , and thus increase the health and productivity of cattle herds (Ciordia et al. 1984 , Dimander et al. 2003 . The utility of ivermectin for malaria control is currently limited, however, because it is not labeled for use in lactating animals, which can comprise ca. 20% of a cattle population in traditional agro-pastoral regions of Africa (Voh and Otchere 1988) . It also requires posttreatment milk and meat withdrawal periods for treated animals, limiting the application of this parasiticide for vector control even further.
The parasiticides moxidectin, doramectin, and eprinomectin are closely related to ivermectin and part of the avermectin/milbemycin family. The mean residence time for moxidectin and doramectin is longer than for ivermectin in the blood of cattle (Lanusse et al. 1997) , and commercially available pour-on formulations of moxidectin and eprinomectin do not require meat or milk withdrawal intervals after treatment. The potential use of these compounds for malaria vector control has not been thoroughly investigated, however. Moxidectin-treated cattle do not reduce An. gambiae s.s. mosquito survivorship as effectively as did cattle treated with ivermectin at the same rate (Fritz et al. 2009 ). Still, the toxic dose of moxidectin required for An. gambiae complex mosquitoes has not been determined. The aim of this study was to determine the concentrations of moxidectin, doramectin, and eprinomectin that reduced survivorship and fecundity of the opportunistic malaria mosquito, An. arabiensis.
Methods
Mosquitoes. In 2009, An. arabiensis of the Dongola strain were acquired from the Malaria Research and Reference Reagent Resource Center (MR4), and reared according to Huang et al. (2005) . Thirty minutes before blood feeding, groups of 20 3Ð5 d old females were aspirated into small, circular plastic cages (10 cm diameter). White mesh covering the top of the cage permitted blood feeding via artiÞcial membrane feeder, while brown paper towel over moist mud served as an ovipositional resource covering the cage ßoor. Throughout the study, cages of adults were always provided cotton moistened with 10% honey solution and held at 25ЊC and 80 Ϯ 10% RH under a 12L:12D cycle.
Preparation of Treated Blood. 6Ј,7,10, 11,14,15,17a,20,20a,20b-dodecahydro-20,20b-dihydroxy-5Ј6,8,19, tetra-methylspiro[11,15-methano-2H,13H, 17H-furo[4,3,2-pq] 
were dissolved in dimethyl sulfoxide (DMSO), then added to deÞbrinated bovine blood (Hemostat Laboratories, Dixon, CA) in a 15 ml plastic conical centrifuge tube and inverted six times. Initial tests of each drug consisted of a 10-fold serial dilution of drug in DMSO, so as to achieve these Þnal concentrations of AI in blood: 1000, 100, 10, and 1 ppb. Control blood contained equivalent concentrations of DMSO. For each drug, cages of mosquitoes were randomly assigned to a single blood concentration, and fed only once throughout the course of the study. Results of the pilot test determined the blood concentrations of each (AI) used in subsequent analyses of survivorship and fecundity (Table 1) . Mosquitoes were blood-fed via artiÞcial membrane feeder, using paraÞlm as a membrane for tests of the drugs eprinomectin and moxidectin. Pork sausage casing (Great Lakes Butcher Supply, Howell, MI) was substituted for paraÞlm during ivermectin and doramectin tests, because it enhanced mosquito acceptance of the artiÞcial feeder. After blood-feeding was complete, unfed mosquitoes were removed from each cage using a mouth aspirator, and the total number of blood-fed mosquitoes was recorded. Cages of mosquitoes were held for 9 d post blood-feeding. Doramectin Extraction and HPLC. Pure doramectin was unavailable, so it was extracted from a commercial injectable formulation for cattle (Dectomax, PÞzer Inc., New York, NY). Five milliliters of ethanol was added to 5 ml Dectomax, and the mixture was allowed to separate after shaking in a separatory funnel (15 min). The top layer was reserved, while 5 ml EtOH was again added to the bottom layer. This process was repeated three times, for a total collection of 15 ml EtOH and doramectin. Thin-layer chromatography conÞrmed the presence of doramectin and absence of other solutes in the extract. Five microliters of the doramectin extract was blotted onto a precoated silica-gel 60 F 254 aluminum backed sheets. These were developed at room temperature using a mixture of hexane-acetone-decane-methanol (59:30:10:1, vol: vol). Sheets were viewed in a dark room under a 340 Ð380 nm UV lamp. After doramectin was conÞrmed present, the extract was dried under a stream of nitrogen for 12 h in a dark hood. The Þnal product was dissolved in DMSO to make a stock solution of expected concentration 10 ppm. The entire extraction process was replicated three times to produce three different doramectin extracts, each used twice during the study. HPLC was used to quantify total doramectin in two of the extracts.
Samples of each extract were diluted with DMSO to a working level for the HPLC/MSD. The LC system was a Waters 2695 HPLC and analytical column Waters XBridge (3.0 ϫ 50 mm) packed with 3.5 m C18 stationary phase. Samples (10 l) were eluted using an isocratic mobile phase consisting of 50% acetonitrile, 50% water, and 0.1% triethylamine at a ßow rate of 0.25 ml min-1. Mass spectrometry (MS) was run at basic pH conditions to promote the formation of analyte anions. Detection by MS in negative ion mode required an atmospheric pressure chemical ionization interface (APCI), and was performed on a Waters MicroMass ZQ mass spectrometer. Ions 591.5 and 815.6 were monitored for detection of doramectin; ion 591.5 was used for quantitation and 815.6 for conÞrmation.
Data Collection and Statistical Analysis. Beginning 1 d post blood-meal, cages were examined for the presence of mosquito carcasses and egg production every other day. Dead females were counted and removed from the cage ßoor; eggs were counted under a dissection microscope. After 9 d of observation, mosquitoes from each cage were frozen at Ϫ20ЊC, and then dissected for the presence of eggs. Eggs present of ChristopherÕs stages IV and V were counted under a dissection microscope. Logistic regression was used to model survivorship and egg deposition data for each drug. For all drugs, survivorship residuals were speciÞed as binomially distributed, and AbbottÕs correction was applied to the mean proportion of individuals deceased at each dose. A log transformation was applied to dosage within each drug treatment, and maximum likelihood estimation (MLE) was used to estimate parameters for mortality models. LC 50 and LC 95 estimates from these models were calculated using the MASS library dose.p program for R statistical software (v. 2.7.2; Anon 2010).
Residual variation in egg production was modeled using a Poisson distribution for each drug. The effect of drug dosage on egg development was explored using a mixed effects model; drug dosage was speciÞed as Þxed, while date of feeding was speciÞed as random. A likelihood ratio test determined the effect of drug dosage on egg production. To determine whether drug and drug dosage inßuenced oviposition relative to total egg development, all egg deposition below each LC 50 was expressed as a proportion over total eggs developed (oviposited ϩ dissected). Within each treatment group, the proportion of eggs deposited by females fed drug dosages below the LC 50 was compared with the proportion of eggs deposited by females fed blood treated only with DMSO. Drug contributions to the proportion of eggs oviposited relative to the total eggs developed (oviposited ϩ dissected) were assessed with a t-test.
Results

A summary of the lethality of the parasiticides on
An. arabiensis can be found in Table 2 . Mortality elicited by treated blood was highly variable among the four compounds. Eprinomectin and ivermectin were highly lethal to An. arabiensis; LC 50 values were 8.5 and 7.9 ppb, respectively. While the concentration required to kill 95% of blood feeding An. arabiensis tended to be lower for eprinomectin than for ivermectin, the difference was not statistically signiÞcant based upon their overlapping 95% conÞdence intervals. Average recovery of doramectin was 80% as determined by HPLC. Thus, expected doramectin dosages (Table 1) were multiplied by a correction factor of 0.8 before statistical analysis. Doramectin and moxidectin were comparatively less lethal, requiring, respectively: three and 148 times the blood concentration to kill An. arabiensis than either eprinomectin or ivermectin. As expected, increasing the amount of The ␣ and ␤ values represent the intercept and slope of the logistic regression analyses, respectively. drug in the proffered blood increased mosquito mortality across all four dewormers ( Figs. 1 and 2) . Three of the four drugs also exerted sub-lethal effects. Surviving individuals having fed upon ivermectin-, doramectin-, and moxidectin-treated blood produced fewer eggs than those that fed upon blood treated with only DMSO (Figs. 1 and 2 ). While egg production tended to be lower for eprinomectin survivors than for mosquitoes fed upon DMSO-treated blood, this difference was not statistically signiÞcant (Table 3 ). An. arabiensis fed upon drug-treated versus DMSO-treated blood deposited the same proportion of their eggs (Table 4) . Therefore, capacity for egg deposition was not inßuenced by drug treatment.
Discussion
The activity of eprinomectin-treated blood against An. arabiensis is equal to ivermectin at low dosages (Table 2 ). It is highly active against An. arabiensis, and Fig. 2 . Uncorrected mean proportion of An. arabiensis deceased (left) and production of eggs by survivors (right) within 9 d of feeding upon doramectin-and moxidectin-treated blood. Error bars represent bootstrapped 95% CIs (N ϭ 1,000). Doramectin doseÐresponse curve was adjusted using HPLC analysis of Þnal extraction product. When treated topically at a rate of 200 g/kg AI, Holstein cattle achieve eprinomectin plasma concentrations of 43Ð76 ng/ml (Alvinerie et al. 1999) , while zebu Gobra only reach plasma concentrations of ca. 8 ng/ml (Bengone-Ndong et al. 2006) . The milk/plasma ratio of 0.094 in eprinomectin-treated zebu Gobra (Bengone-Ndong et al. 2006 ) might permit an increase in the amount of AI applied to zebu Gobra cattle to increase plasma deposition; the maximum concentration of eprinomectin permitted in milk is 30 ng/ml (Alvinerie et al. 1999) . The effects of increased eprinomectin exposure on both zebu Gobra cattle health and safety, and meat withdrawal times should be thoroughly examined. Doramectin-treated blood was less lethal to An. arabiensis than either ivermectin or eprinomectin. Peak plasma concentrations for doramectin and ivermectin are equivalent in cattle treated at the same rate (Lanusse et al. 1997) , suggesting that doramectincaused mosquito mortality would be limited in Þeld situations relative to ivermectin. However, doramectin-treated blood severely reduced egg production at concentrations higher than 10 ppb (Table 3) . Interestingly, doramectin persists at such sub-lethal levels in the blood of cattle for longer than does ivermectin (Lanusse et al. 1997) . Thus, it would function well as a sterilant.
Eprinomectin-treated blood was highly lethal to An. arabiensis, but did not reduce egg production as strongly in survivors. Moxidectin required higher dosages to reduce survivorship and egg production for An. arabiensis. These results suggest variation in mosquito target site sensitivity to each of the drugs. Furthermore, drug interaction with the target site, or in the case of doramectin, the target site itself, may vary according to drug. Some insecticides also modulate insect behaviors in addition to their lethal effects (Haynes 1988 ). While it was beyond the scope of this study, it would be of interest to know whether, and for how long, the avermectins reduce host-seeking behaviors in mosquitoes that have imbibed sub-lethal doses.
Use of doramectin and eprinomectin is not restricted in pregnant animals, and pregnant and lactating animals, respectively, whereas ivermectin currently has such restrictions. The broader applicability of both eprinomectin and doramectin make them better candidates for malaria mosquito control than ivermectin, against those more zoophilic vectors such as An. arabiensis whose primary host is often cattle. Field tests of doramectin-and eprinomectin-treated cattle should be the next step in the investigation of this novel vector control measure. The mass treatment of cattle populations with ivermectin, doramectin, or eprinomectin at the onset of the rainy season, in combination with ITN use, is a promising management technique for zoophilic vectors of malaria like An. arabiensis. 
